Barriers to care include patient embarrassment about their condition, lack of awareness that serious complications can result from mismanagement of incontinence, the perception that bladder issues are ...

Boston Scientific has acquired Valencia Technologies Corporation, a medtech company that focuses on developing and commercializing bladder dysfunction treatment solutions. The company’s flagship ...

The FDA has received a new application for Anktiva plus BCG to treat BCG-unresponsive non–muscle invasive bladder cancer with ...

Treatments for bladder cancer include surgery, chemotherapy, and radiation therapy. Newer treatment options include immunotherapy and targeted therapy. Doctors may administer medications directly into ...

Nearly 200,000 Americans are living with muscle-invasive bladder cancer (MIBC)—and after decades with few major advances, newly presented data may signal a turning point in how the disease is treated.

MSK’s comprehensive program for patients with upper tract urothelial carcinoma (UTUC) offers kidney-sparing treatment options whenever possible. “Traditionally, radical nephroueterectomy has been the ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Researchers have successfully regenerated functional bladder tissue in a baboon using the animal’s own bone marrow cells. With the organ working within a few months and staying healthy throughout the ...

Urinary tract infections (UTIs) are one of the most common bacterial infections, especially among women. While an occasional UTI can happen to anyone, some people find themselves battling them over ...

Noninvasive treatment options for NGB dysfunction include intermittent catheterization, Crede and Valsalva, indwelling catheterization, lifestyle changes/behavioral modification, and oral ...